BioHarvest Sciences Inc. Canadian Securities Exchange

BHSC

CA13767B1013

Food Processing

Delayed Canadian Securities Exchange Other stock markets 07:54:58 05/10/2021 pm IST			5-day change	1st Jan Change
0.35 ^CAD	+6.06%		-2.94%	+46.67%

30/04	BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
16/04	BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	CI

BioHarvest Sciences Inc. Reports Earnings Results for the First quarter Ended March 31, 2021

May 01, 2021 at 02:41 am IST

BioHarvest Sciences Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was USD 313,000 compared to USD 42,000 a year ago. Operating loss was USD 2.232 million compared to USD 1.183 million a year ago. Net loss was USD 6.809 million compared to USD 272,000 a year ago.

Latest news about BioHarvest Sciences Inc.

BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04	CI
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26/02	MT
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02	CI
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02	CI
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding	27/12	CI
Bioharvest Sciences Inc. Announces Major Product Launch of Vinia-Based Functional Coffee Products	13/12	CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Fourth Quarter 2023	29/11	CI
Bioharvest Sciences Inc. Revises Revenue Guidance for the Year 2023	29/11	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding	19/23/19	CI
BioHarvest Sciences Inc. Receives Canadian Product License from Health Canada's Natural and Non-Prescription Health Products Directorate	10/23/10	CI
BioHarvest Sciences Inc. Provides Revenue Guidance for the Third Quarter of 2023	30/23/30	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
BioHarvest Sciences Up After Reporting Closing of Private Placement of Convertible Notes	18/23/18	MT
BioHarvest Sciences Inc. announced that it has received CAD 4.642076 million in funding	18/23/18	CI
BioHarvest Sciences Inc. announced that it expects to receive CAD 4.625103 million in funding	07/23/07	CI
BioHarvest Sciences Inc. Announces Appointment of John Paul Sangiovanni as Medical and Scientific Advisory Board	06/23/06	CI
Bioharvest Sciences Inc. Reiterated Sales Guidance for the year 2023	31/23/31	CI
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	31/23/31	CI
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
BioHarvest Sciences Inc. Auditor Raises 'Going Concern' Doubt	27/23/27	CI
Bioharvest Sciences Inc. Hires Dr. Ilana Belzer as Chief Operating Officer	19/23/19	CI
BioHarvest Sciences Inc. announced that it has received CAD 8 million in funding	21/23/21	CI
BioHarvest Sciences Inc. Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis	14/23/14	CI

Chart BioHarvest Sciences Inc.

Duration

Period

More charts

Company Profile

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.

Sector

Food Processing

Calendar

27/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+16.86%	843.48Cr
BELLRING BRANDS, INC.	+3.57%	748.82Cr
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+4.89%	622.56Cr
THE SIMPLY GOOD FOODS COMPANY	-5.23%	375.26Cr
BYHEALTH CO., LTD	-6.58%	374.69Cr
XIAMEN KINGDOMWAY GROUP COMPANY	-3.55%	133.02Cr
HERBALIFE LTD.	-28.64%	108.86Cr
SIRIO PHARMA CO., LTD.	+18.12%	102.2Cr
USANA HEALTH SCIENCES, INC.	-8.60%	93Cr

Special Foods & Wellbeing Products

BioHarvest Sciences Inc. Canadian Securities Exchange

Equities

BHSC

CA13767B1013

Food Processing

BioHarvest Sciences Inc. Reports Earnings Results for the First quarter Ended March 31, 2021

Latest news about BioHarvest Sciences Inc.

Chart BioHarvest Sciences Inc.

Company Profile

Income Statement Evolution

Sector Special Foods & Wellbeing Products